Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01918254
Brief Title: A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein

First Submitted : July 3, 2013
First Submitted that Met QC Criteria : August 6, 2013
First Posted : August 7, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : September 11, 2017
Last Update Posted : September 12, 2017